BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yeh CN, Chen TW, Wu TJ, Hsueh S, Jan YY. Treatment of patients with advanced gastrointestinal stromal tumor of small bowel: Implications of imatinib mesylate. World J Gastroenterol 2006; 12(23): 3760-3765 [PMID: 16773696 DOI: 10.3748/wjg.v12.i23.3760]
URL: https://www.wjgnet.com/1007-9327/full/v12/i23/3760.htm
Number Citing Articles
1
Firoz Ahmad, Purnima Lad, Simi Bhatia, Bibhu Ranjan Das. Molecular spectrum of c-KIT and PDGFRA gene mutations in gastro intestinal stromal tumor: determination of frequency, distribution pattern and identification of novel mutations in Indian patientsMedical Oncology 2015; 32(1) doi: 10.1007/s12032-014-0424-7
2
Helen Bolanaki, Ioanna Delladetsima, Paraskevi Argyropoulou, Amalia Kapranou, Stylianos Kakolyris, Constantinos Simopoulos, Anastasios J. Karayiannakis. Primary Malignant Gastrointestinal Stromal Tumor (GIST) of the Gallbladder: Report of a CaseJournal of Gastrointestinal Cancer 2012; 43(S1): 151 doi: 10.1007/s12029-011-9346-1
3
Chun-Nan Yeh, Tsann-Long Hwang, Ching-Shui Huang, Po-Huang Lee, Chew-Wun Wu, Ker Chen-Guo, Yi-Yin Jan, Miin-Fu Chen. Clinical practice guidelines for patients with gastrointestinal stromal tumor in TaiwanWorld Journal of Surgical Oncology 2012; 10(1) doi: 10.1186/1477-7819-10-246
4
UMUT KEFELI, MUSTAFA BENEKLI, ALPER SEVINC, RAMAZAN YILDIZ, MUHAMMED ALI KAPLAN, AYDIN CILTAS, OZAN BALAKAN, ABDURRAHMAN ISIKDOGAN, UGUR COSKUN, FAYSAL DANE, HAKAN HARPUTLUOGLU, HALIT KARACA, DOGAN YAZILITAS, AYSE DURNALI, ALI OSMAN KAYA, UMUT DEMIRCI, MAHMUT GUMUS, SULEYMAN BUYUKBERBER. Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experienceOncology Letters 2013; 6(2): 605 doi: 10.3892/ol.2013.1408
5
Chun-Nan Yeh, Tsung-Wen Chen, Feng-Yuan Liu, Yi-Yin Jan, Miin-Fu Chen. Genetic changes in advanced gastrointestinal stromal tumor (GIST) patients during imatinib mesylate treatmentLangenbeck's Archives of Surgery 2006; 391(6): 615 doi: 10.1007/s00423-006-0103-z
6
Yau-Ren Chang, Wen-Kuan Huang, Shang-Yu Wang, Chiao-En Wu, Jen-Shi Chen, Chun-Nan Yeh. A Nomogram Predicting Progression Free Survival in Patients with Gastrointestinal Stromal Tumor Receiving Sunitinib: Incorporating Pre-Treatment and Post-Treatment ParametersCancers 2021; 13(11): 2587 doi: 10.3390/cancers13112587
7
Bernardo H.L. Goulart, Jeffrey W. Clark, Homer H. Pien, Thomas G. Roberts, Stan N. Finkelstein, Bruce A. Chabner. Trends in the Use and Role of Biomarkers in Phase I Oncology TrialsClinical Cancer Research 2007; 13(22): 6719 doi: 10.1158/1078-0432.CCR-06-2860
8
Chun‐Nan Yeh, Tsung‐Wen Chen, Jeng‐Hwei Tseng, Yu‐Yin Liu, Shang‐Yu Wang, Chun‐Yi Tsai, Kun‐Chun Chiang, Tsann‐Long Hwang, Yi‐Yin Jan, Miin‐Fu Chen. Surgical management in metastatic gastrointestinal stromal tumor (GIST) patients after imatinib mesylate treatmentJournal of Surgical Oncology 2010; 102(6): 599 doi: 10.1002/jso.21630
9
Rafael Medrano Guzmán, Nelly Kinakú Meza Bautista, Juan Rodríguez Silverio, Gabriel González Ávila. Factores pronósticos de recurrencia y supervivencia en tumores del estroma gastrointestinal. Experiencia del Hospital de Oncología Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro SocialGaceta Mexicana de Oncología 2015; 14(5): 259 doi: 10.1016/j.gamo.2015.11.002
10
Sunu Philip, Armin Kamyab, Lorenzo Ferguson. Small Bowel Gastrointestinal Stromal Tumors Presenting with Small Bowel ObstructionThe American Surgeon 2013; 79(5): 180 doi: 10.1177/000313481307900501
11
Chun-Nan Yeh, Tsung-Wen Chen, Hsiang-Lin Lee, Yu-Yin Liu, Tzu-Chieh Chao, Tsann-Long Hwang, Yi-Yin Jan, Miin-Fu Chen. Kinase Mutations and Imatinib Mesylate Response for 64 Taiwanese with Advanced GIST: Preliminary Experience from Chang Gung Memorial HospitalAnnals of Surgical Oncology 2007; 14(3): 1123 doi: 10.1245/s10434-006-9288-1
12
Newton A.C.S. Wong, Christel Garcia-Petit, Adam Dangoor, Nicola Andrew. A literature review and database of how the primary KIT/PDGFRA variant of a gastrointestinal stromal tumour predicts for sensitivity to imatinibCancer Genetics 2022; : 46 doi: 10.1016/j.cancergen.2022.09.002
13
Yen-Yang Chen, Chun-Nan Yeh, Chi-Tung Cheng, Chao-En Wu, Kun-Chun Chiang, Tsung-Wen Chen, Chih-Chi Wang, Jen-Shi Chen, Ta-Sen Yeh. Fractioned Dose Regimen of Sunitinib for Patients with Gastrointestinal Stromal Tumor: A Pharmacokinetic and Treatment Efficacy StudyTranslational Oncology 2014; 7(5): 620 doi: 10.1016/j.tranon.2014.08.004